KalVista Pharmaceuticals
KALV
#6259
Rank
NZ$1.46 B
Marketcap
NZ$29.03
Share price
0.18%
Change (1 day)
78.40%
Change (1 year)

KalVista Pharmaceuticals (KALV) - Total debt

Total debt on the balance sheet as of September 2025 : NZ$0.25 Billion

According to KalVista Pharmaceuticals's latest financial reports the company's total debt is NZ$0.25 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

KalVista Pharmaceuticals - Total debt on balance sheet (from 2013 to 2025)

Total debt by year

Year Total debt Change
2025-04-30NZ$10.62 M-14.66%
2024-04-30NZ$12.44 M-6.69%
2023-04-30NZ$13.33 M5.3%
2022-04-30NZ$12.66 M53.67%
2021-04-30NZ$8.24 M206.67%
2020-04-30NZ$2.68 M
2019-04-30N/A-100%
2018-04-30NZ$0.39 M
2015-12-31NZ$6.73 M-19.64%
2014-12-31NZ$8.38 M124.83%
2013-12-31NZ$3.72 M14.2%
2012-12-31NZ$3.26 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
ORIC Pharmaceuticals
ORIC
NZ$5.67 M-97.79%๐Ÿ‡บ๐Ÿ‡ธ USA